Rankings
▼
Calendar
NAGE Q3 2020 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$393M
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$14M
+17.6% YoY
Gross Profit
$8M
59.6% margin
Operating Income
-$4M
-29.6% margin
Net Income
-$4M
-29.7% margin
EPS (Diluted)
$-0.07
QoQ Revenue Growth
-7.2%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$37M
Total Liabilities
$18M
Stockholders' Equity
$19M
Cash & Equivalents
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14M
$12M
+17.6%
Gross Profit
$8M
$7M
+25.3%
Operating Income
-$4M
-$7M
+39.1%
Net Income
-$4M
-$7M
+41.5%
← FY 2020
All Quarters
Q4 2020 →